BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2019 3:14:57 AM | Browse: 830 | Download: 874
 |
Received |
|
2019-04-06 07:30 |
 |
Peer-Review Started |
|
2019-04-08 06:31 |
 |
To Make the First Decision |
|
2019-09-16 03:58 |
 |
Return for Revision |
|
2019-09-18 03:52 |
 |
Revised |
|
2019-09-24 20:25 |
 |
Second Decision |
|
2019-09-25 08:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2019-10-05 07:15 |
 |
Articles in Press |
|
2019-10-05 07:15 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2019-10-21 06:38 |
 |
Publish the Manuscript Online |
|
2019-10-26 03:14 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Medicine, Research & Experimental |
Manuscript Type |
Case Report |
Article Title |
Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature
|
Manuscript Source |
Invited Manuscript |
All Author List |
Vanessa Triviño, Olga Fidalgo, Antia Juane, Jorge Pombo and Fernando Cordido |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
FIS del Instituto de Salud Carlos III (FEDER from E.U.), Spain. |
PI13/00322 and PI16/00884 |
|
Corresponding Author |
Fernando Cordido, MD, PhD, Professor, Endocrinology and Nutrition, Complejo Hospitalario Universitario A Coruña;Instituto de Investigación Biomedica (INIBIC) University Hospital A Coruña; Department of Medicine, Faculty of Health Sciences, As xubias 84, A Coruña 15006, A Coruña, Spain. fernando.cordido.carballido@sergas.es |
Key Words |
Pituitary apoplexy; Pituitary adenoma; Primary hyperparathyroidism; MEN type 1; MEN type 4; Parathyroid carcinoma |
Core Tip |
Pituitary apoplexy represents one of the most serious, life threatening endocrine emergencies. Gonadotropin-releasing hormone agonist can develop pituitary apoplexy in those who have insidious pituitary adenoma coincidentally. What will be discussed in this article is the case of the first female patient who has develop pituitary apoplexy after receiving triptorelin, which is prescribed to regulate the menstrual cycle due menorrhagia, and uterine fibroids through pituitary down regulation. This case demonstrates an uncommon complication of gonadotropin-releasing hormone agonist agonist therapy in the setting of a pituitary macroadenoma and the casual finding of parathyroid carcinoma. It also highlights the importance to suspect the presence of a multiple endocrine neoplasia syndrome and to carry out relevant genetic studies. |
Publish Date |
2019-10-26 03:14 |
Citation |
Triviño V, Fidalgo O, Juane A, Pombo J, Cordido F. Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature. World J Clin Cases 2019; 7(20): 3259-3265 |
URL |
https://www.wjgnet.com/2307-8960/full/v7/i20/3259.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v7.i20.3259 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345